中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
44期
3127-3130
,共4页
黄兴%王蕾%石洪波%张雪军%门晓炜%陈斌%王行环
黃興%王蕾%石洪波%張雪軍%門曉煒%陳斌%王行環
황흥%왕뢰%석홍파%장설군%문효위%진빈%왕행배
癌,肾细胞%胸苷磷酸化酶%预后
癌,腎細胞%胸苷燐痠化酶%預後
암,신세포%흉감린산화매%예후
Carcinoma,renal cell%Thymidine phosphorylase%Prognosis
目的 探讨血小板衍化内皮细胞生长因子(PD-ECGF)在肾细胞癌中的表达及其预后意义.方法 采用免疫组化EnVision两步法检测2002年6月至2006年12月76例肾细胞癌患者肿瘤组织中PD-ECGF的表达水平,并分析其与肾细胞癌患者临床病理特征及预后的关系.结果 76例肾癌患者肿瘤组织中PD-ECGF高表达41例,低表达35例.PD-ECGF表达水平与肿瘤分期及组织学分级呈正相关.PD-ECGF高表达患者5年总生存率(60.98%)显著低于PD-ECFG低表达患者(94.29%,P=0.000).单因素分析显示肿瘤分期、淋巴结转移、远处转移、组织学分级及PD-ECGF表达水平均与肾癌患者5年生存率密切相关,Cox比例风险模型多因素分析显示肿瘤分期、组织学分级及PD-ECGF表达水平为影响肾癌患者预后的独立危险因素(OR=17.971、9.702、6.790,95%CI:3.010~107.290、1.835 ~ 51.305、1.156 ~ 39.894).结论 PD-ECGF在肾细胞癌的发生、发展中可能起重要作用,PD-ECGF高表达可能与肾细胞癌的预后有关.
目的 探討血小闆衍化內皮細胞生長因子(PD-ECGF)在腎細胞癌中的錶達及其預後意義.方法 採用免疫組化EnVision兩步法檢測2002年6月至2006年12月76例腎細胞癌患者腫瘤組織中PD-ECGF的錶達水平,併分析其與腎細胞癌患者臨床病理特徵及預後的關繫.結果 76例腎癌患者腫瘤組織中PD-ECGF高錶達41例,低錶達35例.PD-ECGF錶達水平與腫瘤分期及組織學分級呈正相關.PD-ECGF高錶達患者5年總生存率(60.98%)顯著低于PD-ECFG低錶達患者(94.29%,P=0.000).單因素分析顯示腫瘤分期、淋巴結轉移、遠處轉移、組織學分級及PD-ECGF錶達水平均與腎癌患者5年生存率密切相關,Cox比例風險模型多因素分析顯示腫瘤分期、組織學分級及PD-ECGF錶達水平為影響腎癌患者預後的獨立危險因素(OR=17.971、9.702、6.790,95%CI:3.010~107.290、1.835 ~ 51.305、1.156 ~ 39.894).結論 PD-ECGF在腎細胞癌的髮生、髮展中可能起重要作用,PD-ECGF高錶達可能與腎細胞癌的預後有關.
목적 탐토혈소판연화내피세포생장인자(PD-ECGF)재신세포암중적표체급기예후의의.방법 채용면역조화EnVision량보법검측2002년6월지2006년12월76례신세포암환자종류조직중PD-ECGF적표체수평,병분석기여신세포암환자림상병리특정급예후적관계.결과 76례신암환자종류조직중PD-ECGF고표체41례,저표체35례.PD-ECGF표체수평여종류분기급조직학분급정정상관.PD-ECGF고표체환자5년총생존솔(60.98%)현저저우PD-ECFG저표체환자(94.29%,P=0.000).단인소분석현시종류분기、림파결전이、원처전이、조직학분급급PD-ECGF표체수평균여신암환자5년생존솔밀절상관,Cox비례풍험모형다인소분석현시종류분기、조직학분급급PD-ECGF표체수평위영향신암환자예후적독립위험인소(OR=17.971、9.702、6.790,95%CI:3.010~107.290、1.835 ~ 51.305、1.156 ~ 39.894).결론 PD-ECGF재신세포암적발생、발전중가능기중요작용,PD-ECGF고표체가능여신세포암적예후유관.
Objective To explore the expression and clinical significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) in renal cell carcinoma.Methods The expression of PD-ECGF in 76 specimens of renal cell carcinoma from June 2002 to December 2006 was examined by EnVision immunohistochemistry. The correlation of the expression of PD-ECGF with the clinicopathological characteristics and prognosis in renal cell carcinoma patients were analyzed. Results Among 76 renal cell carcinoma patients,41 patients had a high-level expression of PD-ECGF while another 35 patients a low-level expression.The expression of PD-ECGF was positively correlated with tumor stage and histological grade.The 5-year overall survival rate was significant lower in the patients with a high-level expression of PD-ECGF ( 60.98% vs 94.29%,P =0.000 ). Univariate analysis showed that the characteristics with the prognostic significance for survival were tumor stage,lymph node metastasis,distant metastasis,histological grade and the expression of PD-ECGF. Multivariate analysis showed that tumor stage,histological grade and the expression of PD-ECGF were independent prognostic factors( OR:17.971,9.702,6.790,95% CI:3.010-107.290,1.835 - 51.305,1.156 - 39.894).Conclusion The expression of PD-ECGF may play an important role in the development and invasion of renal cell carcinoma. An elevated level of PD-ECGF is probably correlated with the prognosis of renal cell carcinoma.